Regenxbio (RGNX) Change in Account Payables (2014 - 2025)

Regenxbio's Change in Account Payables history runs 12 years deep, the most recent figure standing at -$1.9 million for Q4 2025.

• In Q4 2025, Change in Account Payables fell 161.26% year-over-year to -$1.9 million; the TTM figure through Dec 2025 stood at -$2.3 million (down 682.19% YoY), while the FY2025 annual figure was -$2.3 million, down 682.19% from the prior year.
• Change in Account Payables for Q4 2025 stood at -$1.9 million, down from $694000.0 in the prior quarter.
• The five-year high for Change in Account Payables was $16.8 million in Q1 2022, with the low at -$14.9 million in Q2 2024.
• The 5-year median for Change in Account Payables is $957000.0 (2023), against an average of $555950.0.
• Peak annual rise in Change in Account Payables reached 5926.98% in 2022, while the deepest fall reached 542.49% in 2022.
• Regenxbio's Change in Account Payables stood at -$8.8 million in 2021, then surged by 121.65% to $1.9 million in 2022, then slumped by 36.03% to $1.2 million in 2023, then soared by 149.02% to $3.0 million in 2024, then plunged by 161.26% to -$1.9 million in 2025.
• Business Quant data shows RGNX's Change in Account Payables at -$1.9 million in Q4 2025, $694000.0 in Q3 2025, and $2.5 million in Q2 2025.